(EMAILWIRE.COM, March 13, 2019 ) The medical simulation market is expected to reach USD 2,575.4 Million by 2022 from USD 1.120.8 Million in 2016, at a CAGR of 14.9% during the forecast period (2017–2022).

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1156

Medical simulation is the advanced methodology for training healthcare professionals through the use of advanced educational technology. Simulation-based medical education is defined as any educational activity that utilizes simulation aides to replicate clinical scenarios. The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the significant growth drivers of the market. The base year considered for the study is 2016 and the forecast period includes 2017 to 2022.

Medical Simulation Market : Objectives of the Study

-To define, describe, and forecast the global market on the basis of product & services, end user and region
-To provide detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges)
-To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market
-To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World, along with major countries in these regions
-To profile the key players and comprehensively analyze their market shares and core competencies in the market
-To track and analyze competitive developments such as partnerships, agreements, collaborations, alliances, mergers and acquisitions, product developments, geographical expansions, and research and development activities in the global Healthcare Simulation market

The prominent players in the global Medical Simulation Market are CAE (Canada), Laerdal Medical (Norway), 3D Systems (US), Simulab Corporation (US), Simulaids (US), Limbs & Things (US), Kyoto Kagaku (Japan), Mentice (Sweden), Medaphor (UK), and Gaumard Scientific Company (US).

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=1156

Laerdal Medical (Norway) held the leading position in the global market in 2016. Over the past three years, the company has been focusing on expanding its product portfolio in various simulation subsegments by launching innovative products in order to lure customers and gain more market share. This is evident from its recent product launches of Nursing Anne Simulator and Little Anne QCPR. The company maintains strong partnerships with leading healthcare research institutes such as American Heart Association (US), American Academy of Pediatrics (US), British Heart Foundation (UK), National League for Nursing (US), and Stavanger Acute Medicine Foundation for Education & Research (Norway) on large-scale projects pertaining to innovative simulation technology development. Innovative products and the company’s brand value helps the company maintain its leading position in the market.